- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 1/08 - Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigoAntiemetics
Patent holdings for IPC class A61P 1/08
Total number of patents in this class: 553
10-year publication summary
|
24
|
24
|
33
|
41
|
55
|
47
|
41
|
36
|
39
|
35
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2699 |
20 |
| Helsinn Healthcare SA | 225 |
15 |
| Acacia Pharma Limited | 21 |
11 |
| Vanda Pharmaceuticals, Inc. | 391 |
11 |
| Cindome Pharma, Inc. | 18 |
9 |
| Altria Client Services LLC | 2449 |
8 |
| Duchesnay Inc. | 63 |
7 |
| Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1358 |
7 |
| Lxo Ireland Designated Activity Company | 35 |
6 |
| Lxo US, Inc. | 17 |
6 |
| Evoke Pharma, Inc. | 30 |
5 |
| Kissei Pharmaceutical Co., Ltd. | 178 |
5 |
| Shionogi & Co., Ltd. | 884 |
5 |
| Alto Neuroscience, Inc. | 83 |
5 |
| Starton Therapeutics, Inc. | 29 |
5 |
| Hoffmann-La Roche Inc. | 3825 |
4 |
| Pfizer Inc. | 3413 |
4 |
| The Trustees of the University of Pennsylvania | 4432 |
4 |
| Adimab, LLC | 156 |
4 |
| Jiangsu Hengrui Medicine Co., Ltd. | 685 |
4 |
| Other owners | 408 |